References
Citations
Centers for Disease Control and Prevention (2006). Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 55(RR-10): 1–44. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr55e628a1.htm. [Erratum: (2006). MMWR, 55(RR-10): 743. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5529a4.htm.]
Centers for Disease Control and Prevention (2002). Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 51(RR-03): 1–31.
Uyeki T, Winquist A (2001). Influenza. Clinical Evidence (6): 550–556.
Centers for Disease Control and Prevention (2006). CDC Health Alert: CDC Recommends Against the Use of Amantadine and Rimantadine for the Treatment or Prophylaxis of Influenza in the United States During the 2005–06 Influenza Season. Available online: http://www.cdc.gov/flu/han011406.htm.
Centers for Disease Control and Prevention (2004). Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 53(RR-6): 1–44. Also available online: http://www.cdc.gov/mmwr/PDF/RR/RR5306.pdf. [Erratum: (2004). MMWR, 53(RR-6): 743. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5332a8.htm.]
Hayden FG, et al. (2000). Inhaled zanamivir for the prevention of influenza in families. New England Journal of Medicine, 343(18): 1282–1289.
© 1995-2007, Healthwise, Incorporated, P.O. Box 1989, Boise, ID 83701. ALL RIGHTS RESERVED.
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information. For more information, click here. Privacy Policy. How this information was developed.
